TABLE 2.
Patient Outcomes from a Mathematical Model of the Use of Fecal Transplantation to Prevent Clostridium difficile Infection and Recurrence in a Simulated 12-Bed Intensive Care Unit over a 1-Year Period
| Scenario, treatment level, % | Median recurrence (25th percentile, 75th percentile) | Pa | Median incidence (25th percentile, 75th percentile) | Pa |
|---|---|---|---|---|
| Baseline, 0 | 2 (0, 6) | 0 (0, 1) | ||
| After infection | ||||
| 20 | 1 (0, 4) | <.001 | 0 (0, 1) | .39 |
| 40 | 1 (0, 4) | 0 (0, 1) | ||
| 60 | 1 (0, 3) | 0 (0, 1) | ||
| 80 | 0 (0, 1) | 0 (0, 2) | ||
| 100 | 0 (0, 1) | 0 (0, 1) | ||
| After receipt of high-risk medication (antibiotics) | ||||
| Antibiotics | ||||
| 20 | 1 (0, 5) | .36 | 0 (0, 1) | .003 |
| 40 | 1 (0, 6) | 0 (0, 1) | ||
| 60 | 1 (0, 6) | 0 (0, 1) | ||
| 80 | 2 (0, 6) | 0 (0, 1) | ||
| 100 | 1 (0, 6) | 0 (0, 1) | ||
| Antibiotics and PPIs | ||||
| 20 | 2 (0, 5.25) | .56 | 0 (0, 1) | .001 |
| 40 | 2 (0, 6) | 0 (0, 1) | ||
| 60 | 1 (0, 5) | 0 (0, 1) | ||
| 80 | 2 (0, 5) | 0 (0, 1) | ||
| 100 | 2 (0, 6) | 0 (0, 1) | ||
| Combined | ||||
| 20 | 1 (0, 5) | <.001 | 0 (0, 1) | .02 |
| 40 | 1 (0, 4) | 0 (0, 1) | ||
| 60 | 1 (0, 3) | 0 (0, 1) | ||
| 80 | 0 (0, 2) | 0 (0, 1) | ||
| 100 | 0 (0, 1) | 0 (0, 1) | ||
NOTE. PPI, proton pump inhibitor.
Kruskal-Wallis 1-way analysis of variance test.